Skip to main content
Leanabl Logo

Design and Development · Medical Device Cybersecurity (SPDF/SBOM)

Engineer IEC 81001-5-1 & FDA §524B medical device cybersecurity files and SBOM evidence.

Modern regulatory authorities mandate a Secure Product Development Framework (SPDF): architecture trust-boundary diagrams, STRIDE threat modeling linked to patient harm (AAMI TIR57), machine-readable SPDX/CycloneDX SBOMs with VEX rationales, fuzzing/pen-test verification, and post-market CVD plans.

Domain Expertise

Deep regulatory authority across every medical device domain

SaMD · AI Digital Health

IEC 62304 & IEC 82304-1 Software Lifecycle · FDA PCCP & Good Machine Learning Practice

Multi-demographic dataset bias control and statistical validation design for Sensitivity, Specificity, and ROC-AUC

Active Devices · Robotics

IEC 60601-1 Ed. 3.2 & IEC 60601-1-2 Ed. 4.1 · IEC 60601-2-XX Particular Standards

Essential Performance definition and worst-case test matrix optimization across FDA, EU Notified Bodies, and MDSAP

Implants · Biomaterials

ISO 10993-1:2018 & ISO 10993-18 E&L · ISO 11135 / 11137 Sterilization & ISO 11607

Biological evaluation plans (BEP), ISO 10993-18 chemical characterization, and toxicological risk assessment (TRA)

In Vitro Diagnostics (IVD)

EU IVDR 2017/746 & FDA IVD Guidance · CLSI EP Guidelines (EP05, EP06, EP12, EP17, EP25)

CLSI-compliant Limit of Detection (LoD), precision, cross-reactivity, interference, and lot-to-lot reproducibility protocols

Proprietary Data & Precedent Validation

Machine-Readable SBOM (CVE/NVD/KEV) Scanner & STRIDE Threat Modeling DB

100% Traceability Across IEC 81001-5-1 SPDF, SBOM CVE Dispositions & Penetration Testing

Engineered 4-Stage Workflow

4-Stage Cybersecurity Pipeline from DFD/SBOM Lock to TPLC Dossier Delivery

Step 01 / 04Stage Gate & Output

Security Architecture Views, Data Flow Diagrams (DFD) & SBOM Locked

Incomplete baseline data or misclassified regulatory pathways are the primary drivers of multi-month submission delays. Gate 01 locks the device scope, predicate/standard mapping, and full document inventory before authoring begins.

Verification Baseline

Device description, intended use, existing test reports, and QMS document index

Gate Sign-Off Output

Confirmed classification matrix and locked submission master inventory

Agentic Automation & Platform Integration

Continuous Post-Market CVE Monitoring & Patch Change Control (TPLC) Automation

Live Traceability: PLM Software BOM ↔ Security Controls ↔ Pen-Test Proof

Links every third-party software component and trust-boundary control directly to SAST, fuzzing, and penetration test verification records.

@Risk Management— Run "Live Traceability: PLM Software BOM ↔ Security Controls ↔ Pen-Test Proof" across our Medical Device Cybersecurity (SPDF/SBOM) records and call out the highest-priority compliance findings first.

I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.

Thought for 4.2s · Explored Risk Management records & 14 regulatory clauses

P1 · Verified Agent Output· Security Architecture Views, Data Flow Diagrams (DFD) & SBOM Locked

Links every third-party software component and trust-boundary control directly to SAST, fuzzing, and penetration test verification records. ISO 14971 risk register linked to design control

Automated Post-Market CVE Triage & Patch Change Control Trigger

Flags newly disclosed CVEs affecting your deployed SBOM and initiates structured impact assessments and patch release workflows.

@Bill of Materials— Run "Automated Post-Market CVE Triage & Patch Change Control Trigger" across our Medical Device Cybersecurity (SPDF/SBOM) records and call out the highest-priority compliance findings first.

I'll inspect the linked quality and dossier records against target regulatory standards, then report actionable findings with verified outputs.

Thought for 4.3s · Explored Bill of Materials records & 14 regulatory clauses

P1 · Verified Agent Output· Single-Source Security Dossier for FDA eSTAR, EU MDR & APAC Updates

Keeps threat models, SBOMs, and V&V evidence synchronized across firmware releases for rapid global change submissions. Multi-level BOM with revisions and comparison

Service Specification

Service Scope & Final Deliverables

Scope

Spans Secure Product Development Framework (SPDF) design, threat modeling, SBOM vulnerability governance, security testing, and TPLC plans.

  • IEC 81001-5-1 Secure Product Development Framework (SPDF) & AAMI TIR57 security risk management linked to ISO 14971
  • Data Flow Diagram (DFD), trust boundary decomposition, STRIDE threat modeling, and attack surface analysis
  • Machine-readable SBOM (SPDX / CycloneDX) generation and NVD CVE/CVSS exploitability & compensating control justification
  • Static/Dynamic analysis (SAST/DAST), protocol fuzz testing, vulnerability scanning, and independent penetration testing
  • FDA Section 524B (eSTAR Cyber Device), EU MDR MDCG 2019-16, and global Post-Market Vulnerability Management (TPLC) dossiers

Deliverables

Comprehensive cybersecurity evidence engineered for FDA Section 524B, EU Notified Bodies, and global authorities.

  • Security Architecture Views, Data Flow Diagrams (DFD) & STRIDE Threat Model Report
  • Cybersecurity Risk Management Plan & Report (AAMI TIR57) linked to ISO 14971 Safety Risk
  • Machine-Readable SBOM (SPDX/CycloneDX) & CVE Vulnerability Justification Matrix
  • SAST/DAST, Protocol Fuzzing & Penetration Testing Report Package
  • Total Product Life Cycle (TPLC) Vulnerability Disclosure, Patching Plan & Security Labeling
Medical Device Cybersecurity (SPDF/SBOM) — Service Scope & Final Deliverables
CategoryItem / MilestoneSpecification & Deliverable
ScopeScope 1IEC 81001-5-1 Secure Product Development Framework (SPDF) & AAMI TIR57 security risk management linked to ISO 14971
ScopeScope 2Data Flow Diagram (DFD), trust boundary decomposition, STRIDE threat modeling, and attack surface analysis
ScopeScope 3Machine-readable SBOM (SPDX / CycloneDX) generation and NVD CVE/CVSS exploitability & compensating control justification
ScopeScope 4Static/Dynamic analysis (SAST/DAST), protocol fuzz testing, vulnerability scanning, and independent penetration testing
ScopeScope 5FDA Section 524B (eSTAR Cyber Device), EU MDR MDCG 2019-16, and global Post-Market Vulnerability Management (TPLC) dossiers
WorkflowStage 1: Security Architecture, DFD & SBOM Baseline LockMap all firmware, OS, cloud, and wireless/network interfaces (BLE, Wi-Fi, DICOM, HL7) into DFDs and extract a complete SBOM.
WorkflowStage 2: STRIDE Threat Modeling & CVE Vulnerability AssessmentMap every threat scenario to cryptographic, authentication, and integrity controls while dispositioning all known CVEs.
WorkflowStage 3: Security V&V, Fuzzing & Penetration TestingExecute security requirement verification, protocol fuzzing, vulnerability scans, and adversarial penetration testing.
WorkflowStage 4: Global Cybersecurity Dossier & TPLC Plan DeliveryCompile the harmonized cybersecurity risk management file, SBOM package, and post-market patch governance plan for global filing.
DeliverablesDeliverable 1Security Architecture Views, Data Flow Diagrams (DFD) & STRIDE Threat Model Report
DeliverablesDeliverable 2Cybersecurity Risk Management Plan & Report (AAMI TIR57) linked to ISO 14971 Safety Risk
DeliverablesDeliverable 3Machine-Readable SBOM (SPDX/CycloneDX) & CVE Vulnerability Justification Matrix
DeliverablesDeliverable 4SAST/DAST, Protocol Fuzzing & Penetration Testing Report Package
DeliverablesDeliverable 5Total Product Life Cycle (TPLC) Vulnerability Disclosure, Patching Plan & Security Labeling

Frequently Asked Questions

What inputs do you need from us?
We usually need the intended use, architecture, data-flow diagrams, SBOM, threat model, risk file, security test evidence, labeling, and vulnerability handling process. If some inputs are missing, we identify that during intake.
Do you perform penetration testing?
Not within this review. We identify where testing evidence is weak or missing. Test execution can be coordinated or scoped separately when needed.
Can you review an SBOM in our existing format?
Yes. We can work from common SBOM formats or structured internal component lists, then identify what needs to be converted, supplemented, or explained for the target market.
Can you help after the gap report?
Yes. Remediation planning, document authoring, testing coordination, or submission support can be scoped as a follow-on project after the gap analysis.
How does Leanabl handle agency Additional Information (AI) requests or Notified Body deficiency letters during Medical Device Cybersecurity (SPDF/SBOM)?
Upon receiving any deficiency notice from FDA, an EU Notified Body, or an international review authority, our engineers dissect the reviewer’s finding against harmonized ISO/IEC clauses and clearance precedents. We separate items resolvable via technical justification from those requiring supplementary bench data, author the formal response dossier, and drive reviewer alignment through closure.
Can we structure one master DHF / IMDRF STED and test campaign to cover FDA, EU MDR, and APAC markets simultaneously?
Yes—that is the core advantage of our universal lifecycle engineering model. By harmonizing FDA eSTAR requirements, EU MDR Annex II/III GSPR checklists, IMDRF STED templates, and multi-country IECEE CB National Deviations before testing or authoring begins, we eliminate redundant laboratory campaigns and prevent region-by-region dossier rewrites.
We have a lean internal RA/QA team—how much bandwidth is required from our R&D engineers?
Our workflow is designed to protect your R&D velocity. Once your team provides baseline engineering inputs (specifications, BOM, architecture diagrams) during Stage 1 intake, Leanabl executes the heavy lifting: standard clause mapping, ISO 14971 risk traceability, regulatory authoring, and laboratory coordination. Your team only reviews and signs off at structured stage gates.
What happens if our hardware, firmware, or software changes during or after the engagement?
We immediately perform a multi-regime regulatory change impact assessment (covering FDA 510(k) modification guidance, EU MDR MDCG 2020-3 significant change criteria, and ISO 13485 design control) to determine whether a formal submission or internal Letter-to-File / QMS update is required. Because deliverables are modularized in our platform, only affected sections require updating.

Bring the evidence you already have. We will show what is missing.

A written scope defines the review, required inputs, deliverables, timeline, and any follow-on work before the project begins.